FDA places hold on Zafgen’s metabolic drug, sending shares tumbling

FDA places hold on Zafgen’s metabolic drug, sending shares tumbling

The company’s shares were down more than 40 percent in midday trading as the FDA placed a clinical hold on ZGN-1061, the second such hold the company has experienced in three years.

Source: https://ift.tt/2r5EBJN